Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study

Marco Valgimigli, Gianluca Campo, Nicoletta De Cesare, Emanuele Meliga, Pascal Vranckx, Alessandro Furgieri, Dominick J. Angiolillo, Manel Sabatè, Martial Hamon, Alessandra Repetto, Salvatore Colangelo, Salvatore Brugaletta, Giovanni Parrinello, Gianfranco Percoco, Roberto Ferrari

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study'. Together they form a unique fingerprint.

Medicine & Life Sciences